Clinical Trial Update: Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the effects of SGLT2 inhibitors on islet cell function and insulin sensitivity in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN